speb/financial-data huggingface dataset:
4482.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Communication Services | Industry: Internet Content & Information
Lynch category:  (confidence: Low)
Market cap (USD): 83124412.94318941
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4482.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Communication Services | Industry: Internet Content & Information
Lynch category:  (confidence: Low)
Market cap (USD): 90305988.83642401
P/B ratio: 5.83612700504014
Pays dividend: no
Net asset value (USD): 10038859.673401605
Net cash (USD): 3852165.7902020477
Net cash to market cap %: 4.265681423609323
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4482.T — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Communication Services | Industry: Internet Content & Information
Lynch category:  (confidence: Low)
Market cap (USD): 101103362.7185437
P/B ratio: 6.092225275362318
Pays dividend: no
Net asset value (USD): 10761108.624768237
Net cash (USD): 5846045.649255164
Net cash to market cap %: 5.782246497111735
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4482.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Communication Services | Industry: Internet Content & Information
Lynch category:  (confidence: High)
Market cap (USD): 91091116.71671672
P/E ratio: 0.10578362178603726
Dividend yield: 0.03
Pays dividend: yes
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4490.T — Peter Lynch category analysis (quarterly, as of 2025-05-31)
Sector: Industrials | Industry: Consulting Services
Lynch category:  (confidence: Low)
Market cap (USD): 52221986.71581583
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4490.T — Peter Lynch category analysis (quarterly, as of 2025-08-31)
Sector: Industrials | Industry: Consulting Services
Lynch category:  (confidence: Low)
Market cap (USD): 47299025.98950882
P/B ratio: 6.838470647273836
Pays dividend: no
Net asset value (USD): 6916608.76081477
Net cash (USD): -9899679.814701278
Net cash to market cap %: -20.92998662783686
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4490.T — Peter Lynch category analysis (quarterly, as of 2026-02-28)
Sector: Industrials | Industry: Consulting Services
Lynch category:  (confidence: Low)
Market cap (USD): 32592129.475170024
P/B ratio: 2.8012392640405
Pays dividend: no
Net asset value (USD): 11634896.702168612
Net cash (USD): -8281111.253689211
Net cash to market cap %: -25.408316016902454
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
4490.T — Peter Lynch category analysis (quarterly, as of 2026-05-31)
Sector: Industrials | Industry: Consulting Services
Lynch category:  (confidence: Low)
Market cap (USD): 36317625.56664783
P/E ratio: 0.06256202547896
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
4492.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 24630985.401409607
Net income (USD): 464186.1989837732
P/E ratio: 53.06272667161017
P/B ratio: 1.6160167709590747
Pays dividend: no
Net asset value (USD): 12977905.261432553
Net cash (USD): -2857285.6908703484
Net cash to market cap %: -11.600371013604793
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.892859133823003 (Safe Zone)
Piotroski F-score: 1 (Weak)
4492.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 23976984.555705704
Net income (USD): 178355.85585585586
EPS growth %: -61.57665690054461
Revenue growth %: 14.709596113421537
Smoothed growth %: -61.57665690054461
P/E ratio: 134.4334024843204
P/B ratio: 1.7121349444072753
Pays dividend: no
Net asset value (USD): 7915765.765765767
Net cash (USD): -8864189.18918919
Net cash to market cap %: -36.9695745876427
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.083661240393115 (Safe Zone)
Piotroski F-score: 2 (Weak)
4492.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 70376995.56629689
Net income (USD): 2738840.464870576
EPS growth %: 1435.604453090713
Revenue growth %: 7.2114012674294585
EPS 2-year CAGR %: 142.90544820187958
Smoothed growth %: 142.90544820187958
P/E ratio: 25.69590907867011
P/B ratio: 4.812828049868231
PEG ratio: 0.17981056287210287
Pays dividend: no
Net asset value (USD): 9508670.100369783
Net cash (USD): -7514745.113576334
Net cash to market cap %: -10.677843026841428
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.624496497667813 (Safe Zone)
Piotroski F-score: 8 (Strong)
4492.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 38741702.49899746
Net income (USD): 2814623.7134072986
EPS growth %: 2.766982944379124
Revenue growth %: 15.044835433684996
EPS 2-year CAGR %: 297.25235888548974
Smoothed growth %: 297.25235888548974
P/E ratio: 13.764434057189806
P/B ratio: 2.411753397987561
PEG ratio: 0.04630555030344525
Pays dividend: no
Net asset value (USD): 7189099.05092902
Net cash (USD): -18445976.473733455
Net cash to market cap %: -47.61271519807575
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.7007504628240175 (Grey Zone)
Piotroski F-score: 4 (Weak)
4492.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Technology | Industry: Software - Application
Lynch category: Stalwart (confidence: Medium)
Market cap (USD): 30404494.094094094
Net income (USD): 3193449.6996996994
EPS growth %: 13.459205381091795
Revenue growth %: 26.542813632172386
EPS 2-year CAGR %: 7.980832670810001
Smoothed growth %: 7.980832670810001
P/E ratio: 0.06762361081373879
P/B ratio: 2.007099607940354
PEG ratio: 0.008473252554344739
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 9599624.624624625
Net cash (USD): -16188757.507507507
Net cash to market cap %: -53.2446205400013
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.3001714667088864 (Safe Zone)
Piotroski F-score: 7 (Neutral)
4493.T — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category:  (confidence: Low)
Market cap (USD): 148619595.94815138
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4493.T — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 129510325.79009932
Net income (USD): 2305191.092386398
P/E ratio: 56.18203463385182
P/B ratio: 13.148095747442483
Pays dividend: no
Net asset value (USD): 7691445.982545893
Net cash (USD): 3626752.9340956975
Net cash to market cap %: 2.800358127408056
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 14.664021022756396 (Safe Zone)
Piotroski F-score: 4 (Weak)
4493.T — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 155346511.39121827
Net income (USD): 3020625.0441914727
EPS growth %: 31.035776347046244
Revenue growth %: 26.390395957103134
Smoothed growth %: 31.035776347046244
P/E ratio: 51.4285980942728
P/B ratio: 12.055025185338412
PEG ratio: 1.6570746456989272
Pays dividend: no
Net asset value (USD): 10410323.128049212
Net cash (USD): 5631033.019868486
Net cash to market cap %: 3.624821033597287
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 16.51856933554025 (Safe Zone)
Piotroski F-score: 8 (Strong)
4493.T — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 125044322.62830175
Net income (USD): 3663290.655455761
EPS growth %: 21.275914814389353
Revenue growth %: 13.546373395177657
EPS 2-year CAGR %: 26.06142808131977
Smoothed growth %: 26.06142808131977
P/E ratio: 34.13442568147643
P/B ratio: 11.504367874152202
PEG ratio: 1.3097680439830999
Pays dividend: no
Net asset value (USD): 8334721.956812535
Net cash (USD): 2276151.3472195687
Net cash to market cap %: 1.820275642569956
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 12.281945185302694 (Safe Zone)
Piotroski F-score: 6 (Neutral)
4493.T — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 116074218.26164989
Net income (USD): 5254798.286554568
EPS growth %: 43.44475447856056
Revenue growth %: 32.29371521945655
EPS 2-year CAGR %: 31.895389702267106
Smoothed growth %: 31.895389702267106
P/E ratio: 22.089186288776972
P/B ratio: 4.106106060788049
PEG ratio: 0.6925510707024497
Pays dividend: no
Net asset value (USD): 23737503.99590819
Net cash (USD): 16444044.498433605
Net cash to market cap %: 14.166836309305216
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 10.474071393773864 (Safe Zone)
Piotroski F-score: 7 (Neutral)
4502.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 38548422012.59974
Net income (USD): 1886297328.306835
P/E ratio: 20.43602640692987
P/B ratio: 0.8275990884487351
Pays dividend: no
Net asset value (USD): -20843099491.886578
Net cash (USD): -54249262415.99738
Net cash to market cap %: -140.73017670675534
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 0.9821279564746879 (Distress Zone)
Piotroski F-score: 3 (Weak)
4502.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 45949519563.07899
Net income (USD): 2380165165.1651654
EPS growth %: 26.18186589394328
Revenue growth %: 3.3743268469604044
Smoothed growth %: 26.18186589394328
P/E ratio: 19.30518110069493
P/B ratio: 0.9631460079998037
PEG ratio: 0.7373493233406581
Pays dividend: no
Net asset value (USD): -20317252252.252254
Net cash (USD): -52923235735.73574
Net cash to market cap %: -115.17690769994518
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.0578833693143042 (Distress Zone)
Piotroski F-score: 8 (Strong)
4502.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 40505969596.486465
Net income (USD): 952172477.5488642
EPS growth %: -59.99552923955213
Revenue growth %: -6.884195075809457
EPS 2-year CAGR %: -28.951856008386766
Smoothed growth %: -59.99552923955213
P/E ratio: 42.540580148629374
P/B ratio: 0.8433076462955291
Pays dividend: no
Net asset value (USD): -15923705758.055996
Net cash (USD): -48612638668.77972
Net cash to market cap %: -120.01351690392923
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 0.968067013341914 (Distress Zone)
Piotroski F-score: 5 (Neutral)
4502.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 45246271059.5395
Net income (USD): 722784387.1140221
EPS growth %: -24.091022986228904
Revenue growth %: 8.760331130823818
EPS 2-year CAGR %: -44.893753063714136
Smoothed growth %: -24.091022986228904
P/E ratio: 62.59995631643565
P/B ratio: 0.9760333870572995
Pays dividend: no
Net asset value (USD): -13506924207.993584
Net cash (USD): -46162117363.98877
Net cash to market cap %: -102.02413653766985
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.1029646985500046 (Distress Zone)
Piotroski F-score: 6 (Neutral)
4502.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: High)
Market cap (USD): 56421746444.044044
Net income (USD): -951732982.982983
EPS growth %: -231.67591884256393
Revenue growth %: -7.943204298194123
Smoothed growth %: -7.943204298194123
P/B ratio: 1.217121162700055
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): -11254485735.735735
Net cash (USD): -46571039789.78979
Net cash to market cap %: -82.54093984130101
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.1431906843470054 (Distress Zone)
Piotroski F-score: 5 (Neutral)
4543.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Medical Instruments & Supplies
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 21568828150.481808
Net income (USD): 727856089.1657106
P/E ratio: 29.633369111749293
P/B ratio: 2.5998168658525476
Pays dividend: no
Net asset value (USD): 4077298803.47484
Net cash (USD): -2098557613.5059826
Net cash to market cap %: -9.729585672734403
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 5.274315301657502 (Safe Zone)
Piotroski F-score: 3 (Weak)
4543.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Medical Instruments & Supplies
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 19166777207.516216
Net income (USD): 670608108.1081082
EPS growth %: -7.865288469760784
Revenue growth %: 6.833844300675803
Smoothed growth %: -7.865288469760784
P/E ratio: 28.581189186019145
P/B ratio: 2.297812746928986
Pays dividend: no
Net asset value (USD): 4300698198.198198
Net cash (USD): -2280285285.285286
Net cash to market cap %: -11.897072004317327
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.930888772877509 (Safe Zone)
Piotroski F-score: 6 (Neutral)
4543.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Medical Instruments & Supplies
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 25805868702.682053
Net income (USD): 702416798.7321712
EPS growth %: 4.743260667366575
Revenue growth %: -1.1434436314740977
EPS 2-year CAGR %: -1.7630919342202067
Smoothed growth %: 4.743260667366575
P/E ratio: 36.73868385445851
P/B ratio: 2.9448196854276425
Pays dividend: no
Net asset value (USD): 4878928948.758584
Net cash (USD): -1804483623.877443
Net cash to market cap %: -6.992531988236846
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 6.359871413775262 (Safe Zone)
Piotroski F-score: 7 (Neutral)
4543.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Medical Instruments & Supplies
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 27213418781.394867
Net income (USD): 781833979.4145168
EPS growth %: 11.306275821661703
Revenue growth %: 13.76691966353263
EPS 2-year CAGR %: 7.974914967792923
Smoothed growth %: 7.974914967792923
P/E ratio: 34.807157910652435
P/B ratio: 2.9752046663565785
PEG ratio: 4.364580443957435
Pays dividend: no
Net asset value (USD): 5502553134.607673
Net cash (USD): -1588009624.381767
Net cash to market cap %: -5.835391859943189
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 7.258565558987866 (Safe Zone)
Piotroski F-score: 9 (Strong)
4543.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Medical Instruments & Supplies
Lynch category: Stalwart (confidence: High)
Market cap (USD): 19975082512.912914
Net income (USD): 850312812.8128128
EPS growth %: 8.758743569776408
Revenue growth %: 2.252040021445358
EPS 2-year CAGR %: 10.025136717910566
Smoothed growth %: 10.025136717910566
P/E ratio: 0.14302340514248116
P/B ratio: 1.9624218293666993
PEG ratio: 0.014266479267755065
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 4886755505.505506
Net cash (USD): -2796515265.2652645
Net cash to market cap %: -14.000018590448645
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.215831245465749 (Safe Zone)
Piotroski F-score: 4 (Weak)
4548.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 339242226.1588264
Net income (USD): 30593345.353220783
P/E ratio: 11.088758755933565
P/B ratio: 0.6239913237646598
Pays dividend: no
Net asset value (USD): 519685297.4922144
Net cash (USD): 190698246.18914932
Net cash to market cap %: 56.213004008489264
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.096332695795283 (Safe Zone)
Piotroski F-score: 3 (Weak)
4548.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 298048148.9844595
Net income (USD): 16786786.786786787
EPS growth %: -45.12928680086462
Revenue growth %: -12.060181038402598
Smoothed growth %: -45.12928680086462
P/E ratio: 17.754925511954387
P/B ratio: 0.5906333825983398
Pays dividend: no
Net asset value (USD): 480367867.8678679
Net cash (USD): 152920420.42042044
Net cash to market cap %: 51.3072874102613
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.001500066229117 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4548.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 254527942.03823295
Net income (USD): 14434759.640781827
EPS growth %: -14.011181388544752
Revenue growth %: -4.796237326827458
EPS 2-year CAGR %: -31.310351548711246
Smoothed growth %: -14.011181388544752
P/E ratio: 17.632987896738335
P/B ratio: 0.5332758476262088
Pays dividend: no
Net asset value (USD): 456160855.7844691
Net cash (USD): 76049920.76069729
Net cash to market cap %: 29.878810220873014
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.331928933476686 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4548.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 258576558.555407
Net income (USD): 8113888.517577863
EPS growth %: -43.78923709505985
Revenue growth %: 10.05150418283853
EPS 2-year CAGR %: -30.476643525758806
Smoothed growth %: -43.78923709505985
P/E ratio: 31.868389366606255
P/B ratio: 0.5286359867604017
Pays dividend: no
Net asset value (USD): 468092501.00253975
Net cash (USD): 53716080.73786926
Net cash to market cap %: 20.77376272542476
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.056515087083232 (Safe Zone)
Piotroski F-score: 7 (Neutral)
4548.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 253473672.07207206
Net income (USD): 9215465.465465466
EPS growth %: 13.576436815728425
Revenue growth %: -12.88170472244988
EPS 2-year CAGR %: -20.098697373341746
Smoothed growth %: 13.576436815728425
P/E ratio: 0.16885637951909702
P/B ratio: 0.5286381674280857
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 452671421.4214214
Net cash (USD): 24436936.936936945
Net cash to market cap %: 9.640818605408695
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.9379349771838053 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4549.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 419769374.27266026
Net income (USD): 50958859.20340928
P/E ratio: 8.237417022957542
P/B ratio: 1.1183462674399565
Pays dividend: no
Net asset value (USD): 364284543.5174562
Net cash (USD): -2196361.252253711
Net cash to market cap %: -0.5232304657907391
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.182771824988421 (Safe Zone)
Piotroski F-score: 3 (Weak)
4549.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 358985685.37710214
Net income (USD): 43063063.06306307
EPS growth %: -15.494452316581603
Revenue growth %: -7.824633185878651
Smoothed growth %: -15.494452316581603
P/E ratio: 8.336278467961993
P/B ratio: 0.9653347860505915
Pays dividend: no
Net asset value (USD): 363963963.963964
Net cash (USD): 14361861.861861855
Net cash to market cap %: 4.000678145919721
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.001488645438501 (Safe Zone)
Piotroski F-score: 6 (Neutral)
4549.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 416976186.6377443
Net income (USD): 17393026.941362917
EPS growth %: -59.6103349269606
Revenue growth %: -18.58753594390801
EPS 2-year CAGR %: -41.577822980078615
Smoothed growth %: -59.6103349269606
P/E ratio: 23.97375615201974
P/B ratio: 1.373653985303894
Pays dividend: no
Net asset value (USD): 298322768.0929741
Net cash (USD): 6365557.316428959
Net cash to market cap %: 1.5265997244967742
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.575444605351083 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4549.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 488761659.8923272
Net income (USD): 14891057.345274696
EPS growth %: -14.384900365664397
Revenue growth %: 2.4471248465085313
EPS 2-year CAGR %: -41.19553418807621
Smoothed growth %: -14.384900365664397
P/E ratio: 32.82249531108169
P/B ratio: 1.67741351392536
Pays dividend: no
Net asset value (USD): 286900147.03916585
Net cash (USD): -56984360.37962839
Net cash to market cap %: -11.658926027909366
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.254498662036329 (Safe Zone)
Piotroski F-score: 5 (Neutral)
4549.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 532101970.7707708
Net income (USD): 23198198.1981982
EPS growth %: 55.78610477623045
Revenue growth %: -3.2536017232852523
EPS 2-year CAGR %: 15.488713223682659
Smoothed growth %: 15.488713223682659
P/E ratio: 0.1706962834943544
P/B ratio: 2.2871443125610336
PEG ratio: 0.011020688486462206
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 273404654.6546546
Net cash (USD): -45839589.58958958
Net cash to market cap %: -8.614812969624811
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.585932415660652 (Safe Zone)
Piotroski F-score: 6 (Neutral)
4553.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 999727715.0385208
P/B ratio: 0.8971279007045485
Pays dividend: no
Net asset value (USD): 782455525.9840313
Net cash (USD): -1698151001.540832
Net cash to market cap %: -169.86135084545498
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
4553.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 861428449.0268012
P/B ratio: 0.7509842711007201
Pays dividend: no
Net asset value (USD): 840683063.7615292
Net cash (USD): -1695816067.3706725
Net cash to market cap %: -196.86093131548193
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
4553.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 995689132.7868806
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4553.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 968639446.2627859
P/B ratio: 0.8002792235972579
Pays dividend: no
Net asset value (USD): 917940780.6191118
Net cash (USD): -1689717362.0457604
Net cash to market cap %: -174.4423447305439
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4553.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: High)
Market cap (USD): 1267346578.5785785
P/E ratio: 0.23509388540351195
P/B ratio: 1.1069864479262
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 947353603.6036036
Net cash (USD): -1575832082.082082
Net cash to market cap %: -124.34105308821621
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
4568.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 37741624193.41829
Net income (USD): 548860842.4848386
P/E ratio: 68.76355766709818
P/B ratio: 3.4090816776725696
Pays dividend: no
Net asset value (USD): 9043050319.619736
Net cash (USD): -218693656.7775774
Net cash to market cap %: -0.5794495108552193
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 5.003643550696549 (Safe Zone)
Piotroski F-score: 3 (Weak)
4568.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 62647163477.46697
Net income (USD): 819729729.7297298
EPS growth %: 49.351104374397686
Revenue growth %: 12.085298003239764
Smoothed growth %: 49.351104374397686
P/E ratio: 76.42416909549219
P/B ratio: 5.771400276375484
PEG ratio: 1.548580727104041
Pays dividend: no
Net asset value (USD): 8918280780.78078
Net cash (USD): -1786103603.6036043
Net cash to market cap %: -2.8510526326479777
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 6.526872814302299 (Safe Zone)
Piotroski F-score: 8 (Strong)
4568.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 54977102292.68027
Net income (USD): 1327363972.530375
EPS growth %: 61.92702599282517
Revenue growth %: 10.191548608155948
EPS 2-year CAGR %: 55.511993621361036
Smoothed growth %: 55.511993621361036
P/E ratio: 41.418257109899216
P/B ratio: 4.930544581055168
PEG ratio: 0.7461136667583391
Pays dividend: no
Net asset value (USD): 9319697569.994717
Net cash (USD): -3620655044.902272
Net cash to market cap %: -6.585750965242
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.547469656184952 (Safe Zone)
Piotroski F-score: 8 (Strong)
4568.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 41640894895.047455
Net income (USD): 1976714343.0022724
EPS growth %: 48.920294953766934
Revenue growth %: 19.199288461407075
EPS 2-year CAGR %: 55.28754126406217
Smoothed growth %: 55.28754126406217
P/E ratio: 21.06571191859844
P/B ratio: 3.837778298474944
PEG ratio: 0.3810209576509329
Pays dividend: no
Net asset value (USD): 8549311589.359711
Net cash (USD): -7431994385.777302
Net cash to market cap %: -17.847825808040508
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 3.8938007963735957 (Safe Zone)
Piotroski F-score: 7 (Neutral)
4568.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Stalwart (confidence: High)
Market cap (USD): 31870114158.958958
Net income (USD): 1625838338.3383384
EPS growth %: -17.750465863014718
Revenue growth %: 5.3568420925038875
EPS 2-year CAGR %: 10.673505788376335
Smoothed growth %: 10.673505788376335
P/E ratio: 0.12338541750306455
P/B ratio: 3.024410735972512
PEG ratio: 0.011559971011346036
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 8294306806.806807
Net cash (USD): -11177852852.852852
Net cash to market cap %: -35.0731497135559
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.943001246250101 (Grey Zone)
Piotroski F-score: 3 (Weak)
456A.T — Peter Lynch category analysis (annual, as of 2024-01-31)
Sector: Consumer Cyclical | Industry: Apparel Manufacturing
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
456A.T — Peter Lynch category analysis (annual, as of 2025-01-31)
Sector: Consumer Cyclical | Industry: Apparel Manufacturing
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 13807560.02595717
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
456A.T — Peter Lynch category analysis (annual, as of 2026-01-31)
Sector: Consumer Cyclical | Industry: Apparel Manufacturing
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 143981604.2047532
Net income (USD): 19202951.162183337
EPS growth %: 39.07563049578084
Smoothed growth %: 39.07563049578084
P/E ratio: 7.497889412347116
P/B ratio: 1.86878585397957
PEG ratio: 0.1918814697860523
Pays dividend: no
Net asset value (USD): 76123837.81666231
Net cash (USD): 47396924.784539044
Net cash to market cap %: 32.91873642214521
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 8.541449103395967 (Safe Zone)
Piotroski F-score: 4 (Weak)
4612.T — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 23846939913.493168
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
4612.T — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 17268030656.99037
Net income (USD): 597743003.3102618
P/E ratio: 28.888720673200933
P/B ratio: 1.9866297905557848
Pays dividend: no
Net asset value (USD): -577437556.4249173
Net cash (USD): -7727437556.424917
Net cash to market cap %: -44.74996431221141
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.059562314927816 (Grey Zone)
Piotroski F-score: 4 (Weak)
4612.T — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 18023815193.366894
Net income (USD): 841384430.4602983
EPS growth %: 40.76023070128234
Revenue growth %: 3.5715028294666427
Smoothed growth %: 40.76023070128234
P/E ratio: 21.42161720713867
P/B ratio: 1.8632428865355022
PEG ratio: 0.5255519126996682
Pays dividend: no
Net asset value (USD): 210676659.83171886
Net cash (USD): -6868733649.155058
Net cash to market cap %: -38.10921037230165
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.25488533241219 (Grey Zone)
Piotroski F-score: 8 (Strong)
4612.T — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 14707339141.987965
Net income (USD): 1154048028.5368495
EPS growth %: 37.16061133975364
Revenue growth %: 10.800473046043953
EPS 2-year CAGR %: 38.94876500103426
Smoothed growth %: 38.94876500103426
P/E ratio: 12.74413090123688
P/B ratio: 1.4363954709696167
PEG ratio: 0.32720243891939754
Pays dividend: no
Net asset value (USD): 1045557041.8497993
Net cash (USD): -6492560035.671061
Net cash to market cap %: -44.145035162311984
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.185936197907797 (Grey Zone)
Piotroski F-score: 7 (Neutral)
4612.T — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 15455375778.18986
Net income (USD): 813458218.7839652
EPS growth %: -29.51262004101323
Revenue growth %: -7.2952334790136675
EPS 2-year CAGR %: -1.6735430979427313
Smoothed growth %: -29.51262004101323
P/E ratio: 18.999593859035596
P/B ratio: 1.3259900461784702
Pays dividend: no
Net asset value (USD): -1785550795.9849114
Net cash (USD): -10171146346.141552
Net cash to market cap %: -65.80976413717973
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.6279878433249186 (Distress Zone)
Piotroski F-score: 5 (Neutral)
4613.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2576929626.92198
Net income (USD): 264259957.3840354
P/E ratio: 9.751494900822452
P/B ratio: 0.8382459500924253
Pays dividend: no
Net asset value (USD): 2221537452.876578
Net cash (USD): -1285469595.1483364
Net cash to market cap %: -49.88376794300622
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.562146726383225 (Grey Zone)
Piotroski F-score: 2 (Weak)
4613.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2173252224.347297
Net income (USD): 221569069.0690691
EPS growth %: -16.154883523622857
Revenue growth %: 11.248300830709763
Smoothed growth %: -16.154883523622857
P/E ratio: 9.808463940740014
P/B ratio: 0.8200045784591197
Pays dividend: no
Net asset value (USD): 1720435435.4354355
Net cash (USD): -1680127627.6276278
Net cash to market cap %: -77.30937112613464
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.1800374349780807 (Grey Zone)
Piotroski F-score: 5 (Neutral)
4613.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2366503147.6141047
Net income (USD): 504140253.5657686
EPS growth %: 127.53187332687416
Revenue growth %: -2.8514241360609196
EPS 2-year CAGR %: 38.121093324589836
Smoothed growth %: 38.121093324589836
P/E ratio: 4.694136464755394
P/B ratio: 0.9425036336337003
PEG ratio: 0.12313750880086806
Pays dividend: no
Net asset value (USD): 1609852086.634971
Net cash (USD): -1377846011.6217647
Net cash to market cap %: -58.22286832835618
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.53821946180296 (Grey Zone)
Piotroski F-score: 8 (Strong)
4613.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2402008137.407432
Net income (USD): 302325892.26039296
EPS growth %: -40.03139203385344
Revenue growth %: 5.995364409301314
EPS 2-year CAGR %: 16.810828741783325
Smoothed growth %: 16.810828741783325
P/E ratio: 7.945095669604723
P/B ratio: 1.0268065619415097
PEG ratio: 0.47261772704026084
Pays dividend: no
Net asset value (USD): 1262471594.70659
Net cash (USD): -1948589760.7271755
Net cash to market cap %: -81.12336217271744
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.1847398527211266 (Grey Zone)
Piotroski F-score: 4 (Weak)
4613.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2931341145.9459457
Net income (USD): 216472722.7227227
EPS growth %: -28.397557647402895
Revenue growth %: -6.239692012311212
EPS 2-year CAGR %: -34.47215252382004
Smoothed growth %: -28.397557647402895
P/E ratio: 0.09872423767110994
P/B ratio: 1.0822745429354668
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 1363257007.007007
Net cash (USD): -1885960960.9609609
Net cash to market cap %: -64.33781900715483
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.2373395015058994 (Grey Zone)
Piotroski F-score: 6 (Neutral)
4615.T — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 43515710.342566796
Net income (USD): -14448451.073594494
P/B ratio: 0.32847429483451906
Pays dividend: no
Net asset value (USD): 123446975.90558925
Net cash (USD): -112719226.35633504
Net cash to market cap %: -259.03110731499146
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.033439564873169 (Distress Zone)
Piotroski F-score: 2 (Weak)
4615.T — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 33474921.741741747
Net income (USD): -13168168.168168169
Revenue growth %: -8.86253257856519
Smoothed growth %: -8.86253257856519
P/B ratio: 0.3099659072645117
Pays dividend: no
Net asset value (USD): 99939939.93993995
Net cash (USD): -112605105.1051051
Net cash to market cap %: -336.38646259982596
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.8040793187890152 (Distress Zone)
Piotroski F-score: 4 (Weak)
4615.T — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 29443076.96777602
Net income (USD): -2879027.997886952
Revenue growth %: -12.43245430067383
Smoothed growth %: -12.43245430067383
P/B ratio: 0.31387157370125307
Pays dividend: no
Net asset value (USD): 86555731.64289488
Net cash (USD): -101525356.57686213
Net cash to market cap %: -344.8191121056287
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.8408638425932828 (Distress Zone)
Piotroski F-score: 7 (Neutral)
4615.T — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 29573736.66622109
Net income (USD): 387648.71006549924
Revenue growth %: 10.849970500344028
Smoothed growth %: 10.849970500344028
P/E ratio: 76.29004275862069
P/B ratio: 0.3027382649151615
Pays dividend: no
Net asset value (USD): 90054805.50728512
Net cash (USD): -98055072.8512231
Net cash to market cap %: -331.56132401496933
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.8976342795006604 (Distress Zone)
Piotroski F-score: 6 (Neutral)
4615.T — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 27469879.47947948
Net income (USD): -2759009.0090090088
EPS growth %: -811.7291860826343
Revenue growth %: -3.133598358933153
Smoothed growth %: -3.133598358933153
P/B ratio: 0.2990537007099177
Pays dividend: no
Net asset value (USD): 81362612.6126126
Net cash (USD): -86955705.7057057
Net cash to market cap %: -316.549279987425
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.9254369452331944 (Distress Zone)
Piotroski F-score: 5 (Neutral)
4633.T — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 357921358.8363636
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
4633.T — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 337209203.529341
Net income (USD): 37127595.546193205
P/E ratio: 9.082441202253293
P/B ratio: 0.48221460283076917
Pays dividend: no
Net asset value (USD): 631417393.9211557
Net cash (USD): -544184471.8627746
Net cash to market cap %: -161.378890661098
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.4602993800753183 (Grey Zone)
Piotroski F-score: 4 (Weak)
4633.T — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 421171145.72466946
Net income (USD): 53121685.63953899
EPS growth %: 43.078712364894045
Revenue growth %: -0.4221178767137047
Smoothed growth %: 43.078712364894045
P/E ratio: 7.928422087027819
P/B ratio: 0.5638072422133459
PEG ratio: 0.1840450109063356
Pays dividend: no
Net asset value (USD): 670953828.7492045
Net cash (USD): -505013080.67595273
Net cash to market cap %: -119.90685634625429
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.637514685382626 (Grey Zone)
Piotroski F-score: 8 (Strong)
4633.T — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 504681568.33647937
Net income (USD): 65246194.02509714
EPS growth %: 22.824027964454803
Revenue growth %: -3.122923548266042
EPS 2-year CAGR %: 32.56509257200377
Smoothed growth %: 32.56509257200377
P/E ratio: 7.735034600521712
P/B ratio: 0.6645749369911162
PEG ratio: 0.23752533739675366
Pays dividend: no
Net asset value (USD): 670017198.5476781
Net cash (USD): -551207083.2537104
Net cash to market cap %: -109.21878622803433
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.610246178026787 (Grey Zone)
Piotroski F-score: 6 (Neutral)
4633.T — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 724812465.1291585
Net income (USD): 84125055.94271466
EPS growth %: 28.934809454718096
Revenue growth %: 5.315586268337367
EPS 2-year CAGR %: 25.842332472256512
Smoothed growth %: 25.842332472256512
P/E ratio: 8.6158928158422
P/B ratio: 0.8960686522036696
PEG ratio: 0.33340228963821056
Pays dividend: no
Net asset value (USD): 716092321.4628221
Net cash (USD): -503497218.8478998
Net cash to market cap %: -69.46586090488644
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.960985880281571 (Grey Zone)
Piotroski F-score: 9 (Strong)
4634.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 924359715.5377623
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
4634.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 950904897.9000831
P/B ratio: 0.5235807988102305
Pays dividend: no
Net asset value (USD): 1703549681.7049541
Net cash (USD): -912544976.4738443
Net cash to market cap %: -95.96595605817676
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
4634.T — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1019607708.8414845
P/B ratio: 0.5752780014930419
Pays dividend: no
Net asset value (USD): 1662297807.0455854
Net cash (USD): -878888817.8505211
Net cash to market cap %: -86.19872233499947
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
4634.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1330587035.035035
P/E ratio: 0.10964147066941479
Dividend yield: 0.03
Pays dividend: yes
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
463A.T — Peter Lynch category analysis (annual, as of 2022-05-31)
Sector: Real Estate | Industry: Real Estate - Diversified
Lynch category: Turnaround (confidence: High)
Market cap (USD): 39634050.67217092
Net income (USD): 5035584.598528721
P/E ratio: 7.870794323215432
P/B ratio: 0.4227795827926261
Pays dividend: no
Net asset value (USD): 89258522.46047895
Net cash (USD): -191930599.46783534
Net cash to market cap %: -484.25683525352997
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.5382371595367106 (Distress Zone)
Piotroski F-score: 1 (Weak)
463A.T — Peter Lynch category analysis (annual, as of 2023-05-31)
Sector: Real Estate | Industry: Real Estate - Diversified
Lynch category: Asset Play (confidence: High)
Market cap (USD): 33108223.038486302
Net income (USD): 720952.8578582159
EPS growth %: -85.68283694272834
Revenue growth %: 4.300190823822769
Smoothed growth %: -85.68283694272834
P/E ratio: 45.922868156516046
P/B ratio: 0.3930708103128252
Pays dividend: no
Net asset value (USD): 79982752.7004793
Net cash (USD): -206665090.4928822
Net cash to market cap %: -624.2107595223295
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.480315790574224 (Distress Zone)
Piotroski F-score: 4 (Weak)
463A.T — Peter Lynch category analysis (annual, as of 2024-05-31)
Sector: Real Estate | Industry: Real Estate - Diversified
Lynch category: Asset Play (confidence: High)
Market cap (USD): 31498947.141064037
Net income (USD): 2638827.652118509
EPS growth %: 266.01944542641183
Revenue growth %: -7.768256352321869
EPS 2-year CAGR %: -27.609668585493495
Smoothed growth %: 266.01944542641183
P/E ratio: 11.936720124853924
P/B ratio: 0.4163990490908979
Pays dividend: no
Net asset value (USD): 74959917.1710736
Net cash (USD): -152008614.2083466
Net cash to market cap %: -482.5831591373366
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.7871947514303117 (Distress Zone)
Piotroski F-score: 8 (Strong)